Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Vernon · SciRah

Researcher profile · Semantic Scholar

A. Vernon

Share profile

A. Vernon — researcher profile on SciRah

h-index: 33
Works: 58
Citations: 5,243

Most-cited papers

Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial.
D. Benator, Mondira Bhattacharya, L. Bozeman, W. Burman +15 more
2002The Lancet405 citations
Semantic Scholar
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
S. Dorman, Payam Nahid, E. Kurbatova, P. Phillips +27 more
2021New England Journal of Medicine374 citations Open access
Semantic Scholar
Moxifloxacin-containing regimen greatly reduces time to culture conversion in murine tuberculosis.
E. Nuermberger, T. Yoshimatsu, S. Tyagi, R. O'Brien +4 more
2004American Journal of Respiratory and Critical Care Medicine324 citations
Semantic Scholar
Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium.
A. Vernon, W. Burman, D. Benator, Awal Khan +1 more
1999The Lancet322 citations
Semantic Scholar
Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.
S. Dorman, J. E. Johnson, S. Goldberg, Grace Muzanye +15 more
2009American Journal of Respiratory and Critical Care Medicine265 citations
Semantic Scholar
Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis.
W. Burman, S. Goldberg, J. E. Johnson, Grace Muzanye +8 more
2006American Journal of Respiratory and Critical Care Medicine263 citations
Semantic Scholar
Association between acquired rifamycin resistance and the pharmacokinetics of rifabutin and isoniazid among patients with HIV and tuberculosis.
M. Weiner, D. Benator, W. Burman, C. Peloquin +6 more
2005Clinical Infectious Diseases242 citations
Semantic Scholar
Effect of Duration and Intermittency of Rifampin on Tuberculosis Treatment Outcomes: A Systematic Review and Meta-Analysis
D. Menzies, A. Benedetti, A. Paydar, I. Martín +5 more
2009PLoS Medicine211 citations Open access
Semantic Scholar
Standardized Treatment of Active Tuberculosis in Patients with Previous Treatment and/or with Mono-resistance to Isoniazid: A Systematic Review and Meta-analysis
D. Menzies, A. Benedetti, A. Paydar, S. Royce +4 more
2009PLoS Medicine210 citations Open access
Semantic Scholar
Low isoniazid concentrations and outcome of tuberculosis treatment with once-weekly isoniazid and rifapentine.
M. Weiner, W. Burman, A. Vernon, D. Benator +6 more
2003American Journal of Respiratory and Critical Care Medicine204 citations Open access
Semantic Scholar
Lack of weight gain and relapse risk in a large tuberculosis treatment trial.
Awal Khan, T. Sterling, R. Reves, A. Vernon +1 more
2006American Journal of Respiratory and Critical Care Medicine200 citations
Semantic Scholar
Acquired rifamycin resistance with twice-weekly treatment of HIV-related tuberculosis.
W. Burman, D. Benator, A. Vernon, Awal Khan +8 more
2006American Journal of Respiratory and Critical Care Medicine165 citations Open access
Semantic Scholar
Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults
J. E. Johnson, A. Okwera, D. Hom, H. Mayanja +10 more
2001AIDS (London)165 citations Open access
Semantic Scholar
Effects of Tuberculosis, Race, and Human Gene SLCO1B1 Polymorphisms on Rifampin Concentrations
M. Weiner, C. Peloquin, W. Burman, Chi-Cheng Luo +6 more
2010Antimicrobial Agents and Chemotherapy154 citations Open access
Semantic Scholar
Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis.
W. Burman, S. Weis, A. Vernon, A. Khan +8 more
2007The International Journal of Tuberculosis and Lung Disease134 citations
Semantic Scholar
Treatment of Latent Tuberculosis Infection
A. Vernon
2013Seminars in Respiratory and Critical Care Medicine130 citations Open access
Semantic Scholar
Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial.
S. Dorman, R. Savic, S. Goldberg, J. Stout +14 more
2015American Journal of Respiratory and Critical Care Medicine116 citations Open access
Semantic Scholar
Substitution of rifapentine for rifampin during intensive phase treatment of pulmonary tuberculosis: study 29 of the tuberculosis trials consortium.
S. Dorman, S. Goldberg, J. Stout, G. Muzanyi +14 more
2012Journal of Infectious Diseases108 citations
Semantic Scholar
Targeted tuberculin testing and treatment of latent tuberculosis infection - Supplement - American Thoracic Society Centers for Disease Control and Prevention
David L. Cohn, Richard J. O'Brien, Lawrence Geiter, Fred M. Gordin +43 more
1999104 citations
Semantic Scholar
Mortality in a large tuberculosis treatment trial: modifiable and non-modifiable risk factors.
T. Sterling, Z. Zhao, Awal Khan, R. Chaisson +4 more
2006The International Journal of Tuberculosis and Lung Disease94 citations
Semantic Scholar
Pharmacokinetics of rifapentine at 600, 900, and 1,200 mg during once-weekly tuberculosis therapy.
M. Weiner, N. Bock, C. Peloquin, W. Burman +7 more
2004American Journal of Respiratory and Critical Care Medicine89 citations
Semantic Scholar
Effectiveness of Once-Weekly Rifapentine and Moxifloxacin Regimens against Mycobacterium tuberculosis in Mice
N. Lounis, Abdelhalim Bentoucha, C. Truffot-Pernot, B. Ji +4 more
2001Antimicrobial Agents and Chemotherapy89 citations Open access
Semantic Scholar
Is there a risk to contacts of patients with rabies?
C. Helmick, R. V. Tauxe, A. Vernon
1987Reviews of Infectious Diseases88 citations
Semantic Scholar
The effects of local review on informed consent documents from a multicenter clinical trials consortium.
W. Burman, P. Breese, S. Weis, N. Bock +2 more
2003Controlled Clinical Trials87 citations
Semantic Scholar
A prospective, randomized, double-blind study of the tolerability of rifapentine 600, 900, and 1,200 mg plus isoniazid in the continuation phase of tuberculosis treatment.
N. Bock, T. Sterling, C. Hamilton, C. Pachucki +5 more
2002American Journal of Respiratory and Critical Care Medicine76 citations
Semantic Scholar
Evaluation of the drug interaction between rifabutin and efavirenz in patients with HIV infection and tuberculosis.
M. Weiner, D. Benator, C. Peloquin, W. Burman +4 more
2005Clinical Infectious Diseases61 citations
Semantic Scholar
2,3-butanediol: an unusual metabolite in the serum of severely alcoholic men during acute intoxication.
D. Rutstein, RitaJ Nickerson, A. Vernon, Punyamurtula Kishore +4 more
1983The Lancet57 citations
Semantic Scholar
Exposure to Latent Tuberculosis Treatment during Pregnancy
R. Moro, N. Scott, A. Vernon, Naomi K. Tepper +12 more
2018Annals of the American Thoracic Society51 citations Open access
Semantic Scholar
The value of end-of-treatment chest radiograph in predicting pulmonary tuberculosis relapse
C. D. Hamilton, Jason E. Stout, Philip C. Goodman, A. Mosher +5 more
2008The International Journal of Tuberculosis and Lung Disease47 citations
Semantic Scholar
Isoniazid-associated hepatitis and antiretroviral drugs during tuberculosis prophylaxis in hiv-infected adults in Botswana.
Z. Tedla, S. Nyirenda, C. Peeler, T. Agizew +5 more
2010American Journal of Respiratory and Critical Care Medicine44 citations
Semantic Scholar
In-Person vs Electronic Directly Observed Therapy for Tuberculosis Treatment Adherence
J. Burzynski, J. Mangan, Chee-Kin Lam, M. Macaraig +6 more
2022JAMA Network Open41 citations Open access
Semantic Scholar
High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: study protocol for TBTC Study 31/ACTG A5349 phase 3 clinical trial
S. Dorman, Payam Nahid, E. Kurbatova, S. Goldberg +28 more
2020Contemporary Clinical Trials40 citations Open access
Semantic Scholar
The Royal College of Radiologists' Clinical Oncology Information Network. British Association of Urological Surgeons. Guidelines on the management of prostate cancer.
M. Mason, P. Malone, N. Clarke, D. Kirk +15 more
1999Clinics in oncology34 citations
Semantic Scholar
Antituberculosis activity of once-weekly rifapentine-containing regimens in mice. Long-term effectiveness with 6- and 8-month treatment regimens.
Nathalie Daniel, N. Lounis, B. Ji, R. O'Brien +6 more
2000American Journal of Respiratory and Critical Care Medicine33 citations
Semantic Scholar
Novel Regimens of Bedaquiline-Pyrazinamide Combined with Moxifloxacin, Rifabutin, Delamanid and/or OPC-167832 in Murine Tuberculosis Models
R. Tasneen, Andrew Garcia, P. Converse, M. Zimmerman +7 more
2021bioRxiv27 citations Open access
Semantic Scholar
Pleural effusion resulting from metastatic papillary carcinoma of the thyroid.
A. Vernon, L. Sheeler, C. Biscotti, James K. Stoller
1992Chest26 citations
Semantic Scholar
The Association between Symptoms and Microbiologically Defined Response to Tuberculosis Treatment
C. Hales, C. Heilig, R. Chaisson, Chi-Chiu Leung +9 more
2013Annals of the American Thoracic Society25 citations Open access
Semantic Scholar
Capacity building for international tuberculosis control through operations research training.
K. Laserson, N. Binkin, L. Thorpe, R. Laing +20 more
2005The International Journal of Tuberculosis and Lung Disease24 citations
Semantic Scholar
Changes in use of health services in a rural health zone in Zaire.
A. Vernon, W. R. Taylor, A. Biey, K. M. Mundeke +4 more
1993International Journal of Epidemiology15 citations
Semantic Scholar
Rifapentine with and without moxifloxacin for pulmonary tuberculosis in people with HIV (S31/A5349).
A. Pettit, P. Phillips, E. Kurbatova, A. Vernon +18 more
2022Clinical Infectious Diseases14 citations Open access
Semantic Scholar
Factors associated with loss to follow-up in a large tuberculosis treatment trial (TBTC Study 22).
D. Conwell, A. Mosher, Awal Khan, Jan Tapy +3 more
2007Contemporary Clinical Trials14 citations
Semantic Scholar
A Phase II Study Of A Rifapentine-Containing Regimen For Intensive Phase Treatment Of Pulmonary Tuberculosis: Preliminary Results For Tuberculosis Trials Consortium Study 29
S. Dorman, S. Goldberg, Pei-Jean I. Feng, C. Heilig +13 more
2011Asian Test Symposium13 citations
Semantic Scholar
Factors associated with non-completion of follow-up: 33-month latent tuberculous infection treatment trial
Ruth N. Moro, T. Sterling, Jussi J. Saukkonen, A. Vernon +5 more
2017The International Journal of Tuberculosis and Lung Disease10 citations Open access
Semantic Scholar
Using a medication event monitoring system to evaluate self-report and pill count for determining treatment completion with self-administered, once-weekly isoniazid and rifapentine
N. Scott, Claire Sadowski, A. Vernon, Bert Arevalo +11 more
2023Contemporary Clinical Trials8 citations Open access
Semantic Scholar
Another step on the path to better TB therapies.
A. Vernon, W. Burman, C. Horsburgh
2002The International Journal of Tuberculosis and Lung Disease8 citations
Semantic Scholar
2,3-Butanediol in serum of alcoholics.
J. Kuehnle, J. Holzbaur, D. Rutstein, RitaJ Nickerson +6 more
19838 citations
Semantic Scholar
A Reader’s Guide to the Bactericidal Activity of Pyrazinamide and Clofazimine Alone and in Combinations with Pretomanid and Bedaquiline
J. Grosset, A. Vernon
2015American Journal of Respiratory and Critical Care Medicine7 citations Open access
Semantic Scholar
Quality assurance in a large clinical trials consortium: the experience of the Tuberculosis Trials Consortium.
Laurie Sandman, A. Mosher, Awal Khan, Jan Tapy +3 more
2006Contemporary Clinical Trials7 citations
Semantic Scholar
Advancing the science in clinical trials for new TB drugs.
W. Burman, D. Mcneeley, L. Moulton, M. Spigelman +1 more
2008The International Journal of Tuberculosis and Lung Disease5 citations
Semantic Scholar
A Standardized Approach for Collection of Objective Data to Support Outcome Determination for Late-Phase TB Trials.
E. Kurbatova, P. Phillips, S. Dorman, E. Sizemore +27 more
2023American Journal of Respiratory and Critical Care Medicine4 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

W. Burman×16
Invite
W. Burman — researcher profile on SciRah
M. Weiner×14
Invite
M. Weiner — researcher profile on SciRah
R. Chaisson×13
Invite
R. Chaisson — researcher profile on SciRah
Awal Khan×12
Invite
Awal Khan — researcher profile on SciRah

×11

Invite

S. Goldberg — researcher profile on SciRah

J. E. Johnson×10

Invite

J. E. Johnson — researcher profile on SciRah

Invite

S. Dorman — researcher profile on SciRah

Invite

D. Benator — researcher profile on SciRah

Invite

L. Bozeman — researcher profile on SciRah

Invite

Payam Nahid — researcher profile on SciRah

Invite

N. Schluger — researcher profile on SciRah

M. Villarino×6

Invite

M. Villarino — researcher profile on SciRah